Incidence and determinants of venous thromboembolism over 90 days in hospitalized and nonhospitalized patients with COVID‐19

COVID‐19 is associated with an increased risk of venous thromboembolism (VTE), but there is great variation among reported incidence rates. Most previous studies have focused on hospitalized patients with COVID‐19, and only a few reports are from population‐based registries.

[1]  Jonathan A. Cooper,et al.  Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales , 2022, Circulation.

[2]  R. Paredes,et al.  Clinical and Genetic Risk Factors for Acute Incident Venous Thromboembolism in Ambulatory Patients With COVID-19 , 2022, JAMA internal medicine.

[3]  F. Klok,et al.  Estimating incidence of venous thromboembolism in COVID‐19: Methodological considerations , 2022, Research and Practice in Thrombosis and Haemostasis.

[4]  L. Poisson,et al.  Venous thromboembolism in COVID-19 patients and prediction model: a multicenter cohort study , 2022, BMC Infectious Diseases.

[5]  C. Russ,et al.  Thrombotic and bleeding events, mortality, and anticoagulant use among 546,656 hospitalized patients with COVID-19 in the United States: a retrospective cohort study , 2022, Journal of Thrombosis and Thrombolysis.

[6]  P. Tuppin,et al.  One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes. , 2022, Thrombosis and haemostasis.

[7]  D. Savary,et al.  Risk of symptomatic venous thromboembolism in mild and moderate COVID-19: A comparison of two prospective European cohorts , 2021, Thrombosis Research.

[8]  A. Ashrani,et al.  Timing of venous thromboembolism diagnosis in hospitalized and non-hospitalized patients with COVID-19 , 2021, Thrombosis Research.

[9]  K. Telle,et al.  Occupational risk of COVID-19 in the first versus second epidemic wave in Norway, 2020 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  R. Bajpai,et al.  Venous thromboembolism is linked to severity of disease in COVID‐19 patients: A systematic literature review and exploratory meta‐analysis , 2021, International journal of clinical practice.

[11]  A. Go,et al.  COVID-19 and Risk of VTE in Ethnically Diverse Populations , 2021, Chest.

[12]  H. Poor.  Pulmonary Thrombosis and Thromboembolism in COVID-19 , 2021, Chest.

[13]  J. Pell,et al.  Thromboembolic Risk in Hospitalized and Nonhospitalized COVID-19 Patients , 2021, Mayo Clinic Proceedings.

[14]  L. Bertoletti,et al.  Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis , 2021, Thorax.

[15]  I. Martín-Loeches,et al.  The incidence of venous thromboembolism in critically ill patients with COVID-19 compared with critically ill non-COVID patients , 2021, Irish Journal of Medical Science (1971 -).

[16]  K. Telle,et al.  COVID-19 among immigrants in Norway, notified infections, related hospitalizations and associated mortality: A register-based study , 2021, Scandinavian journal of public health.

[17]  A. Pottegård,et al.  Venous thromboembolism and major bleeding in patients with COVID-19: A nationwide population-based cohort study. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[18]  M. Grøsland,et al.  Hospitalisations for COVID-19 - a comparison of different data sources. , 2020, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[19]  D. Jiménez,et al.  Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019 , 2020, Chest.

[20]  S. Goldhaber,et al.  Registry of Arterial and Venous Thromboembolic Complications in Patients With COVID-19 , 2020, Journal of the American College of Cardiology.

[21]  M. Di Nisio,et al.  Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis , 2020, Thrombosis Research.

[22]  Sharon J Peacock,et al.  Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.

[23]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[24]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.

[25]  R. Raimondi.  Comorbidity Index , 2020, Definitions.

[26]  S. Vollset,et al.  The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: Research potential of two nationwide health-care registries , 2020, Scandinavian journal of public health.

[27]  L. Vold,et al.  Evaluation of the national surveillance of Legionnaires' disease in Norway, 2008-2017 , 2019, BMC Public Health.

[28]  Jaakko Reinikainen,et al.  Time-varying covariates and coefficients in Cox regression models. , 2018, Annals of translational medicine.

[29]  A. Løvlie,et al.  MSIS celebrates 40 years. , 2015, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[30]  Lau Caspar Thygesen,et al.  When the entire population is the sample: strengths and limitations in register-based epidemiology , 2014, European Journal of Epidemiology.

[31]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[32]  A Bouckaert,et al.  Practical considerations on the use of the Charlson comorbidity index with administrative data bases. , 1996, Journal of clinical epidemiology.

[33]  J. Kongerud,et al.  Interval censoring in longitudinal data of respiratory symptoms in aluminium potroom workers: a comparison of methods. , 1994, Statistics in medicine.

[34]  E. B. Wilson.  Probable Inference, the Law of Succession, and Statistical Inference , 1927 .

[35]  Lynne M Connelly,et al.  Fisher's Exact Test. , 2016, Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses.

[36]  K. Sullivan,et al.  OpenEpi: Open Source Epidemiologic Statistics for Public Health. Version 2.3.1. , 2013 .

[37]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.